Literature DB >> 15961168

Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.

Yamima Talukder1, Robin Gopal, Nick Andrews, Michael Glenn, Judith Breuer, David Brown.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for detection of Varicella zoster virus (VZV) antibodies in oral fluid is described. The assay was optimised and evaluated using paired serum and oral fluid from healthy adult volunteers (n = 205) and preschool children (n = 98), oral fluid samples collected for routine measles, mumps and rubella testing (n = 537) and samples from a study of atopic dermatitis (n = 252). As chickenpox is predominantly a childhood disease and most adults are immune, it was crucial to have samples from children aged 1-5 years to evaluate the assay. Mixture modelling of the oral fluid results was used to determine the optimum cut-off, sensitivity and specificity of the assay. Compared to paired sera tested by the same ELISA the sensitivity of the oral fluid assay was 93% and specificity 95.7% overall, varying slightly with age group. The assay was shown to have good potential for use in large-scale epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961168     DOI: 10.1016/j.jviromet.2005.04.013

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Evaluation of biological sample preparation for immunosignature-based diagnostics.

Authors:  Brian Andrew Chase; Stephen Albert Johnston; Joseph Barten Legutki
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

2.  Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture models.

Authors:  P Hardelid; D Williams; C Dezateux; P A Tookey; C S Peckham; W D Cubitt; M Cortina-Borja
Journal:  Epidemiol Infect       Date:  2008-02-25       Impact factor: 2.451

3.  Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.

Authors:  Stefani N Thomas; Amy B Karger; Ghaith Altawallbeh; Kathryn M Nelson; David R Jacobs; Jed Gorlin; Helene Barcelo; Bharat Thyagarajan
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

4.  Use of Saccharomyces cerevisiae-expressed recombinant nucleocapsid protein to detect Hantaan virus-specific immunoglobulin G (IgG) and IgM in oral fluid.

Authors:  Rasa Petraityte; Li Jin; Rashpal Hunjan; Ausra Razanskiene; Aurelija Zvirbliene; Kestutis Sasnauskas
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

Review 5.  Saliva and viral infections.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  Periodontol 2000       Date:  2016-02       Impact factor: 7.589

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.